Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Suicide in epileptic patients].

M Wolfersdorf1, W Fröscher

  • 1Psychiatrisches Landeskrankenhaus Weissenau, Abteilung Psychiatrie I der Universität Ulm.

Fortschritte Der Neurologie-Psychiatrie
|October 1, 1987
PubMed
Summary

Epilepsy patients have a higher risk of suicide, occurring four times more frequently than in the general population. Pharmacogenic depressive moods, especially with phenobarbital, require prompt medication changes for suicide prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Current psychopharmacological and psychotherapeutic strategies for prevention of suicide : When a person is tired of life…].

Der Nervenarzt·2016
Same author

[Suicide in psychiatric hospitals : Results, risk factors and therapeutic measures].

Der Nervenarzt·2016
Same author

The influence of folate serum levels on depressive mood and mental processing in patients with epilepsy treated with enzyme-inducing anti-epileptic drugs.

Acta neuropsychiatrica·2016
Same author

[Suicidal behavior: a psychiatric emergency situation, suicide prevention: a psychiatric obligation].

Der Nervenarzt·2015
Same author

[Anticonvulsant therapy for brain tumour-related epilepsy].

Fortschritte der Neurologie-Psychiatrie·2014
Same author

A paradox in suicide statistics in estimating specificity of tests for suicide - reply to Mushquash and co-workers and Culver.

Journal of psychiatric research·2014

Area of Science:

  • Neurology
  • Psychiatry
  • Clinical Pharmacology

Context:

  • Epilepsy is associated with a significantly elevated risk of suicide, accounting for approximately 8% of mortality in affected individuals.
  • This increased suicide rate is roughly four times higher compared to the general population.
  • Affective disorders, including depression, are common comorbidities in epilepsy patients, manifesting during or between seizures.

Purpose:

  • To investigate the relationship between epilepsy and suicide risk.
  • To identify potential causes of affective disorders contributing to suicide in epilepsy.
  • To highlight the importance of recognizing and managing pharmacogenically induced depression, particularly with phenobarbital.

Summary:

  • Suicide risk is elevated in epilepsy patients due to reactive, pharmacogenic, or epilepsy-related factors.
  • Pharmacogenic depressive moods, especially linked to phenobarbital, are a critical concern for suicide prophylaxis.
  • Management involves recognizing drug-induced depression and considering medication changes, alongside general crisis intervention strategies for suicidal patients.

Impact:

  • Informing clinicians about the heightened suicide risk in epilepsy.
  • Emphasizing the need for vigilant monitoring of mood disorders in epilepsy patients.
  • Guiding therapeutic interventions, including medication adjustments, to mitigate suicide risk and improve patient outcomes.

Related Experiment Videos